ReMODE

ReMODE: Deep learning-based de novo ligand design and optimization platform

ReMODE generates and optimizes small-molecule ligands for specific protein targets using deep learning-based generative models for de novo drug design.

Key Features:

• Target-Specific Design: Constructs ligand design tasks for user-selected protein targets to generate target-optimized molecules.
• Generative Deep Learning Models: Applies state-of-the-art deep learning-based generative models to create novel molecular structures with defined properties.
• Molecular Optimization: Optimizes drug-likeness, synthetic accessibility, and physicochemical properties of generated molecules.
• Fragment-Based Drug Design: Supports fragment- and scaffold-based design to guide generation of novel compounds.
• Pharmacophore Matching and Docking Optimization: Improves pharmacophore alignment and docking conformations to enhance predicted protein–ligand interactions.

Scientific Applications:

• Drug Discovery and Chemical Biology: Designs and optimizes target-specific ligands to support early-stage drug development and biological target validation.

Methodology:

ReMODE employs deep learning algorithms trained on large molecular datasets to generate candidate structures and integrates modular workflows for target selection, ligand generation, pharmacophore matching, docking conformation optimization, and multi-parameter molecular optimization.